Abstract:Background: Ameloblastoma is a locally invasive and aggressive epithelial odontogenic neoplasm. The BRAF-V600E gene mutation is a prevalent genetic alteration found in this tumor and is considered to have a crucial role in its pathogenesis. The objective of this study is to develop and validate a radiomics-based machine learning method for the identification of BRAF-V600E gene mutations in ameloblastoma patients. Methods: In this retrospective study, data from 103 patients diagnosed with ameloblastoma who underwent BRAF-V600E mutation testing were collected. Of these patients, 72 were included in the training cohort, while 31 were included in the validation cohort. To address class imbalance, synthetic minority over-sampling technique (SMOTE) is applied in our study. Radiomics features were extracted from preprocessed CT images, and the most relevant features, including both radiomics and clinical data, were selected for analysis. Machine learning methods were utilized to construct models. The performance of these models in distinguishing between patients with and without BRAF-V600E gene mutations was evaluated using the receiver operating characteristic (ROC) curve. Results: When the analysis was based on radiomics signature, Random Forest performed better than the others, with the area under the ROC curve (AUC) of 0.87 (95%CI, 0.68-1.00). The performance of XGBoost model is slightly lower than that of Random Forest, and its AUC is 0.83 (95% CI, 0.60-1.00). The nomogram evident that among younger women, the affected region primarily lies within the mandible, and patients with larger tumor diameters exhibit a heightened risk. Additionally, patients with higher radiomics signature scores are more susceptible to the BRAF-V600E gene mutations. Conclusions: Our study presents a comprehensive radiomics-based machine learning model using five different methods to accurately detect BRAF-V600E gene mutations in patients diagnosed with ameloblastoma. The Random Forest model's high predictive performance, with AUC of 0.87, demonstrates its potential for facilitating a convenient and cost-effective way of identifying patients with the mutation without the need for invasive tumor sampling for molecular testing. This non-invasive approach has the potential to guide preoperative or postoperative drug treatment for affected individuals, thereby improving outcomes.

Recent methods for the diagnosis and differentiation of ameloblastoma: a narrative review

Ameloblastoma with Varied Sites of Metastasis: Report of Two Cases and Literature Review

[Computed tomographic features of desmoplastic ameloblastoma of the jaw].

Machine learning-based radiomics for predicting BRAF-V600E mutations in ameloblastoma

A Retrospective Study of 158 Cases on the Risk Factors for Recurrence in Ameloblastoma

Targeted therapies in ameloblastomas and amelobastic carcinoma—A systematic review

Indirect comparison of the diagnostic performance of 18F-FDG PET/CT and MRI in differentiating benign and malignant ovarian or adnexal tumors: a systematic review and meta-analysis

Molecular pathogenesis of ameloblastoma

The efficacy of CBCT-based radiomics techniques in differentiating between conventional and unicystic ameloblastoma

Curettage combined with decompression for the treatment of ameloblastoma in children: report of two cases

Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: A review

Function and Therapeutic Potential of Non-Coding RNA in Ameloblastoma

The Effect of Conservative vs. Radical Treatment of Ameloblastoma on Recurrence Rate and Quality of Life: An Umbrella Review

Recurrent Ameloblastoma Accompanied Metastasis to the Lung: A Case Report and Literatures Review

Giant Mandibular Ameloblastoma with Rare Hypercalcemia: A Case Report and Literature Review

Ameloblastic carcinoma: A systematic review

Multidisciplinary Approach to Mandibular Ameloblastoma: A Case Report on Surgical and Prosthetic Management

Tumor microenvironment of ameloblastoma with a focus on osteoclastogenesis, cell migration, and malignant transformation

The 'D–M–C' strategy for conventional ameloblastoma of the mandible: a retrospective study

New diagnostic molecular markers and biomarkers in odontogenic tumors

Clinicopathological characteristics and diagnostic accuracy of BRAF mutations in ameloblastoma: A Bayesian network analysis